What is Biospatial?
Headquartered in Research Triangle Park, North Carolina, Biospatial operates at the intersection of big data and emergency medical services. By aggregating a vast network of over 100 million electronic patient care records (ePCRs) from thousands of EMS providers, the company provides near real-time visibility into public health trends. Its platform utilizes sophisticated artificial intelligence to synthesize disparate healthcare data sources, enabling enterprise-level customers to enhance situational awareness and optimize operational outcomes. The company's unique position as a data aggregator for data-hungry industries positions it as a vital utility in the modern healthcare ecosystem.
How much funding has Biospatial raised?
Biospatial has raised a total of $3.4M across 1 funding round:
Series A
$3.4M
Series A (2022): $3.4M with participation from East Carolina Angels, Cofounders Capital, Front Porch Ventures, and Gratus Private Capital
Key Investors in Biospatial
East Carolina Angels
A regional investment group focused on supporting early-stage ventures and fostering innovation within the North Carolina business ecosystem.
Cofounders Capital
A venture capital firm specializing in seed-stage B2B software investments, with a strategic focus on supporting high-growth startups in the Southeast.
Front Porch Ventures
An investment entity that provides capital and liquidity solutions, often engaging in property-related asset management and strategic financial support.
What's next for Biospatial?
With the successful closure of this major strategic investment, Biospatial is well-positioned to accelerate its product development roadmap and deepen its penetration into the public health and emergency response markets. The company is expected to focus on enhancing its AI-driven predictive modeling capabilities, which will allow for more granular analysis of patient outcomes and resource allocation. By scaling its data network and refining its proprietary algorithms, Biospatial aims to solidify its status as an indispensable partner for organizations requiring high-fidelity, real-time health intelligence to inform critical decision-making processes.
See full Biospatial company page
